In this in-depth interview, you share powerful insights into the realities of cancer care today, addressing common misconceptions, the emotional and financial toll on patients, and the urgent need to move beyond trial-and-error treatment models. You also discuss how First Ascent Biomedical is advancing Functional Precision Medicine (FPM) through AI and robotics to personalize therapy selection, improve outcomes, and reduce unnecessary toxicity and cost.